VERY IMPRESSIVE "ONCOLIX" CEO INTERVIEW (4/24/17)>>> https://www.youtube.com/watch?v=Ox6n1HH8v_0&feature=youtu.be 1. PRIVATE COMPANY "ONCOLIX" RECENTLY PURCHASED PUBLIC SHELL COMPANY "AEPP". 2. "ONCOLIX" HAS 8 PATENTS IN U.S. AND PATENTS IN OTHER COUNTRIES. 3. ALL "AEPP" DEBT WAS PAID OFF BY "ONCOLIX" AT PURCHASE. 4. "AEPP" HAS A LOW FLOAT: 33,311,633 a/o Apr 06, 2017 PER OTCMARKETS.COM: https://www.otcmarkets.com/stock/AEPP/profile 5. "ONCOLIX" HAS ORPHAN DRUG "PROLANTA" CURRENTLY IN FDA-APPROVED PHASE 1 TRIALS. 6. INVENTOR OF "PROLANTA" ALSO INVENTED "SOMAVERT" SOLD BY PFIZER. "SOMAVERT" YIELDED $232M IN REVS LAST YEAR. 7. JUNE 2017 "ONCOLIX" PRESENTATION SLIDES!!! https://nebula.wsimg.com/f9ea3e25d6e15d3ee2d410b787195b45?AccessKeyId=D34B304F5C474C27E878&disposition=0&alloworigin=1 8. BRAND NEW "ONCOLIX" WEBSITE: https://www.oncolixbio.com/home.html